Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 32401-32450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06109779
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
PHASE3Recruiting
750 participants
Started: Dec 4, 2023 · Completed: May 3, 2030
1 condition1 sponsor209 locations
NCT06361706
VR-Enhanced Psychoeducation for Chronic Pain: A Primary Care Pilot Study
NARecruiting
60 participants
Started: Dec 4, 2023 · Completed: Mar 31, 2026
2 conditions2 sponsors4 locations
NCT05094037
Orthotic Treatment of Diabetic Foot Ulcers
NARecruiting
175 participants
Started: Dec 4, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor2 locations
NCT06073431
An Observational Research Study to Uncover Subtypes of Cancer Cachexia
N/ARecruiting
800 participants
Started: Dec 4, 2023 · Completed: Aug 21, 2031
9 conditions2 sponsors195 locations
NCT05754593
Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group
NARecruiting
160 participants
Started: Dec 4, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06085664
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
PHASE1/PHASE2Recruiting
42 participants
Started: Dec 4, 2023 · Completed: Jun 15, 2026
2 conditions1 sponsor1 location
NCT06267664
Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)
N/ARecruiting
1,500 participants
Started: Dec 4, 2023 · Completed: Dec 1, 2024
4 conditions1 sponsor1 location
NCT06056583
Drug Excretion in Breast Milk
PHASE4Recruiting
50 participants
Started: Dec 4, 2023 · Completed: Sep 30, 2028
6 conditions2 sponsors1 location
NCT06009926
Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters
PHASE2Recruiting
66 participants
Started: Dec 4, 2023 · Completed: Nov 1, 2027
3 conditions1 sponsor1 location
NCT06222775
Multicomponent Intervention on Lifestyle, Anthropometric Measurements, Glycemic Control and Quality of Life in Patients Obese People With Type II Diabetes
NARecruiting
100 participants
Started: Dec 4, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06299553
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)
N/ARecruiting
200 participants
Started: Dec 4, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06140901
Bronchial Epithelium of Children With Post-infectious Bronchiolitis Obliterans
NARecruiting
450 participants
Started: Dec 4, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT06603454
Preoperative Chest CT-imaging in Surgical Aortic Valve Replacement with or Without CABG
NARecruiting
380 participants
Started: Dec 4, 2023 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT06284837
Secondary Access - FEmoral or Radial in Transcatheter Aortic Valve Implantation?
NARecruiting
542 participants
Started: Dec 4, 2023 · Completed: Aug 31, 2026
1 condition3 sponsors3 locations
NCT05628376
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
N/ARecruiting
600 participants
Started: Dec 4, 2023 · Completed: Jun 30, 2034
3 conditions2 sponsors1 location
NCT05664854
Electrical Impedance Tomography & Selective Stimulation of Vagus Nerve
NARecruiting
50 participants
Started: Dec 4, 2023 · Completed: Jan 31, 2027
3 conditions2 sponsors1 location
NCT06379542
Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections
PHASE3Recruiting
252 participants
Started: Dec 4, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor6 locations
NCT06034002
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
PHASE1Recruiting
230 participants
Started: Dec 4, 2023 · Completed: Oct 29, 2028
1 condition1 sponsor13 locations
NCT05914987
Determining Individualized Cancer Therapy in Pancreatic Cancer
N/ARecruiting
1,000 participants
Started: Dec 4, 2023 · Completed: Aug 1, 2033
1 condition1 sponsor1 location
NCT06206005
Four Mandibular Implant-retained Overdentures in Individuals With Type 2 Diabetes
N/ARecruiting
20 participants
Started: Dec 4, 2023 · Completed: Aug 5, 2024
1 condition2 sponsors1 location
NCT05826743
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy
NARecruiting
256 participants
Started: Dec 4, 2023 · Completed: Mar 15, 2027
5 conditions1 sponsor3 locations
NCT06306378
The Relationship Between Social Memory Disorders and Sleep Spindles in Children With Autism Spectrum Disorder
N/ARecruiting
60 participants
Started: Dec 4, 2023 · Completed: Apr 30, 2024
1 condition2 sponsors1 location
NCT05968573
Persuasive Health Communication Intervention for HIV/HCV
NARecruiting
2,000 participants
Started: Dec 4, 2023 · Completed: Aug 1, 2026
2 conditions2 sponsors1 location
NCT06164613
Use of Cinnamomum Verum for Induction of Labor. Double Blind Randomized Clinical Trial
PHASE2Recruiting
32 participants
Started: Dec 4, 2023 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location
NCT06152913
HANDS-ON: a Personalized, Brief and Intensive Exposure-based Intervention for Youth With Persistent Anxiety or OCD
NARecruiting
12 participants
Started: Dec 4, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT03516968
Monthly Boluses Versus Daily Doses for Correcting Blood Vitamin D Deficit in Obese Children and Adolescents
PHASE3Recruiting
68 participants
Started: Dec 4, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor4 locations
NCT06005740
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
PHASE1Recruiting
70 participants
Started: Dec 4, 2023 · Completed: Oct 31, 2026
2 conditions2 sponsors10 locations
NCT06100237
Teclistamab or Talquetamab in Combination With Daratumumab for High-Risk Smoldering Myeloma (REVIVE Study)
PHASE2Recruiting
50 participants
Started: Dec 4, 2023 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT05882253
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)
NARecruiting
225 participants
Started: Dec 4, 2023 · Completed: Apr 30, 2028
1 condition2 sponsors1 location
NCT05854836
Preconception Intervention for Incarcerated Women With Substance Use
NARecruiting
90 participants
Started: Dec 4, 2023 · Completed: Mar 1, 2027
1 condition2 sponsors1 location
NCT06167460
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
N/ARecruiting
50 participants
Started: Dec 4, 2023 · Completed: Dec 1, 2025
5 conditions1 sponsor1 location
NCT06846619
"Patient Satisfaction with Intra-Oral Vs. Extra-Oral Scanned 3D-Printed Dentures: an in Vivo Study"
NARecruiting
8 participants
Started: Dec 3, 2023 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT06512207
A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
NARecruiting
80 participants
Started: Dec 3, 2023 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT05833126
Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation
PHASE2Recruiting
25 participants
Started: Dec 3, 2023 · Completed: Apr 1, 2025
1 condition1 sponsor1 location
NCT06224257
Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
PHASE2Recruiting
41 participants
Started: Dec 3, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors3 locations
NCT06640309
The Effect of Nicotinamide on the Clinical Outcome of Rheumatoid Arthritis Patients
PHASE2Recruiting
70 participants
Started: Dec 2, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06159608
Sex Differences in the Vascular Effects of E-cigarette Use
EARLY_PHASE1Recruiting
80 participants
Started: Dec 2, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06238765
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
N/ARecruiting
1,500 participants
Started: Dec 2, 2023 · Completed: Dec 31, 2099
1 condition1 sponsor1 location
NCT05998759
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
PHASE2Recruiting
296 participants
Started: Dec 2, 2023 · Completed: Dec 31, 2025
2 conditions23 sponsors23 locations
NCT06149273
Treatment of Insomnia in Primary Care Study
NARecruiting
250 participants
Started: Dec 2, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06091475
Therapy to Maintain Remission in Dilated Cardiomyopathy
NARecruiting
50 participants
Started: Dec 2, 2023 · Completed: Sep 15, 2026
4 conditions2 sponsors1 location
NCT06186921
Intraligamentary Injections and Post-endodontic Pain
NARecruiting
140 participants
Started: Dec 2, 2023 · Completed: Mar 3, 2024
1 condition1 sponsor1 location
NCT06033183
Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology
NARecruiting
100 participants
Started: Dec 2, 2023 · Completed: Oct 30, 2027
3 conditions5 sponsors2 locations
NCT05893459
Beneficial or Fostering Future Struggles (B.F.F.s)? Characterizing the Role of Friends in the Development of 13- to 17-Year-Old Adolescents
NARecruiting
120 participants
Started: Dec 2, 2023 · Completed: Mar 1, 2025
5 conditions2 sponsors1 location
NCT06302114
Upper Extremity Asymmetries in Overhead Athletes
NARecruiting
58 participants
Started: Dec 1, 2023 · Completed: Mar 30, 2024
3 conditions2 sponsors1 location
NCT06196047
Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
PHASE3Recruiting
900 participants
Started: Dec 1, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT04602754
Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
PHASE3Recruiting
228 participants
Started: Dec 1, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06537843
Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia
PHASE2Recruiting
100 participants
Started: Dec 1, 2023 · Completed: Jul 1, 2028
1 condition5 sponsors5 locations
NCT06173934
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
NARecruiting
50 participants
Started: Dec 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06084520
Translation and Validation of the COMM and ASI-SR
N/ARecruiting
400 participants
Started: Dec 1, 2023 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location